Get the Stockscreener App
8.20
1.11%
0.09
Aura Biosciences Inc Stock (AURA) Forecast
The Aura Biosciences Inc (AURA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.23, representing a +36.90% increase from the current price of $8.20. The highest analyst price target is $17.29, and the lowest is $5.1627.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AURA Price Target
Average 9.5772
(+16.80% Upside)
Is Aura Biosciences Inc (AURA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.04 | Neutral |
| STOCH(9,6) | 31.56 | Neutral |
| STOCHRSI(14) | 47.49 | Neutral |
| MACD(12,26) | -0.3428 | Sell |
| ADX(14) | 18.12 | Neutral |
| William %R | -84.80 | Buy |
| CCI(14) | -85.23 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.535
Sell
|
8.4884
Sell
|
| MA20 |
8.6975
Sell
|
8.7507
Sell
|
| MA50 |
9.6888
Sell
|
9.1325
Sell
|
| MA100 |
9.1047
Sell
|
9.0583
Sell
|
| MA200 |
8.4057
Sell
|
8.8681
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, AURA could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on AURA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.04 indicates that AURA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 31.56 indicates that AURA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 47.49 indicates that AURA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.12 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -85.23 indicates that AURA is still oversold but not to an extreme extent.
Long-term AURA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aura Biosciences Inc financial reports and earnings history, Aura Biosciences Inc (AURA) stock could reach $6.3048 by 2030, $19.75 by 2040 and $45.50 by 2050. See the projected annual prices until 2050 of the Aura Biosciences Inc stock below:
- Aura Biosciences Inc (AURA) is expected to reach an average price of $25.04 in 2035, with a high prediction of $25.80 and a low estimate of $25.78. This indicates an $205.34% rise from the last recorded price of $8.20.
- Aura Biosciences Inc (AURA) stock is projected to chart a bullish course in 2040, with an average price target of $18.47, representing an $125.25% surge from its current level. The forecast ranges from a conservative $19.40 to a sky-high $19.75.
- Our analysts predict Aura Biosciences Inc (AURA) to jump 253.68% by 2045, soaring from $32.97 to an average price of $29.00, potentially reaching $33.03. While $32.97 is the low estimate, the potential upside is significant.
- Aura Biosciences Inc (AURA) stock is expected to climb by 2050, reaching an average of $45.16, a $450.69% jump from its current level. However, a wide range of estimates exists, with high and low targets of $45.50 and $45.90, respectively, highlighting the market's uncertainty.
Aura Biosciences Inc Stock (AURA) Year by Year Forecast
Aura Biosciences Inc Stock (AURA) Price Forecast for 2025
Aura Biosciences Inc Stock (AURA) is expected to reach an average price of $9.5772 in 2025, with a high prediction of $17.29 and a low estimate of $1.8654. This indicates an +16.80% rise from the last recorded price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.8863 | $5.1627 | $17.29 | -28.22% |
| February, 2025 | $7.5206 | $5.5599 | $10.23 | -8.29% |
| March, 2025 | $5.285 | $4.565 | $11.87 | -35.55% |
| April, 2025 | $7.0829 | $4.2657 | $7.3029 | -13.62% |
| May, 2025 | $5.2872 | $4.3536 | $7.4101 | -35.52% |
| June, 2025 | $3.7316 | $2.628 | $5.7058 | -54.49% |
| July, 2025 | $3.5295 | $2.9123 | $5.218 | -56.96% |
| August, 2025 | $3.5238 | $3.4538 | $5.7431 | -57.03% |
| September, 2025 | $3.2682 | $3.0882 | $4.5282 | -60.14% |
| October, 2025 | $2.8761 | $1.8654 | $3.5261 | -64.93% |
| November, 2025 | $5.1705 | $2.7347 | $7.0405 | -36.95% |
| December, 2025 | $6.7384 | $5.004 | $7.5712 | -17.82% |
Aura Biosciences Inc Stock (AURA) Price Forecast for 2026
The predicted value for Aura Biosciences Inc (AURA) in 2026 is set at an average of $4.0809. Estimates vary from a peak of $7.2609 to a trough of $0.9009, indicating an -50.23% surge from the present price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.0827 | $5.4677 | $6.982 | -25.82% |
| February, 2026 | $5.1171 | $4.7571 | $6.7463 | -37.60% |
| March, 2026 | $4.9814 | $4.2542 | $5.602 | -39.25% |
| April, 2026 | $3.6994 | $2.6494 | $5.205 | -54.89% |
| May, 2026 | $3.0037 | $1.4437 | $3.9429 | -63.37% |
| June, 2026 | $3.008 | $0.9009 | $7.2609 | -63.32% |
| July, 2026 | $3.866 | $2.8616 | $4.2574 | -52.85% |
| August, 2026 | $2.9903 | $2.7803 | $4.6267 | -63.53% |
| September, 2026 | $4.2882 | $2.5911 | $4.5382 | -47.70% |
| October, 2026 | $3.9626 | $3.9426 | $5.2354 | -51.68% |
| November, 2026 | $2.9169 | $2.6198 | $4.3898 | -64.43% |
| December, 2026 | $3.2856 | $2.6877 | $3.8835 | -59.93% |
Aura Biosciences Inc Stock (AURA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aura Biosciences Inc (AURA) is $4.8971, with a high forecast of $9.7482 and a low forecast of $0.046. This indicates an -40.28% decrease from the last price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.9515 | $0.0657 | $2.5572 | -88.40% |
| February, 2027 | $1.1802 | $0.0687 | $5.253 | -85.61% |
| March, 2027 | $4.4761 | $0.5374 | $6.6289 | -45.41% |
| April, 2027 | $1.4247 | $0.0953 | $7.4528 | -82.63% |
| May, 2027 | $0.3834 | $0.0737 | $2.6291 | -95.32% |
| June, 2027 | $0.7607 | $0.0894 | $2.7793 | -90.72% |
| July, 2027 | $1.342 | $1.672 | $1.3692 | -83.63% |
| August, 2027 | $1.0233 | $1.6898 | $0.6733 | -87.52% |
| September, 2027 | $1.5875 | $0.046 | $9.7482 | -80.64% |
| October, 2027 | $0.1812 | $0.5988 | $2.854 | -97.79% |
| November, 2027 | $1.9201 | $0.0916 | $4.5634 | -76.58% |
| December, 2027 | $0.0458 | $1.8492 | $1.6308 | -99.44% |
Aura Biosciences Inc Stock (AURA) Price Forecast for 2028
In 2028, Aura Biosciences Inc (AURA) is projected to reach an average price of $1.7666, with a high projection of $3.5121 and a low estimate of $0.0211. This indicates an -78.46% fall from the last price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6155 | $0.6799 | $0.5855 | -80.30% |
| February, 2028 | $3.0369 | $2.3884 | $2.664 | -62.97% |
| March, 2028 | $3.071 | $3.2482 | $2.711 | -62.55% |
| April, 2028 | $2.9423 | $2.8495 | $2.4523 | -64.12% |
| May, 2028 | $3.3165 | $2.8808 | $2.8165 | -59.56% |
| June, 2028 | $3.2878 | $3.5778 | $3.5121 | -59.91% |
| July, 2028 | $0.8591 | $1.6191 | $2.3706 | -89.52% |
| August, 2028 | $0.8768 | $0.0289 | $1.6424 | -89.31% |
| September, 2028 | $0.3555 | $0.0211 | $1.154 | -95.67% |
| October, 2028 | $0.4758 | $0.278 | $1.0526 | -94.20% |
| November, 2028 | $0.99 | $0.7272 | $0.3172 | -87.93% |
| December, 2028 | $1.5913 | $1.5128 | $1.4963 | -80.59% |
Aura Biosciences Inc Stock (AURA) Price Forecast for 2029
The 2029 price forecast for Aura Biosciences Inc Stock (AURA) is $4.174 on average, with a high prediction of $8.30 and a low estimate of $0.048. This represents an -49.10% decrease from the previous price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.7346 | $2.2354 | $2.0926 | -78.85% |
| February, 2029 | $1.9568 | $2.1268 | $2.1717 | -76.14% |
| March, 2029 | $0.9881 | $1.5909 | $1.6596 | -87.95% |
| April, 2029 | $1.7294 | $0.8737 | $1.0694 | -78.91% |
| May, 2029 | $0.2635 | $1.1935 | $1.3422 | -96.79% |
| June, 2029 | $0.4548 | $0.048 | $0.7508 | -94.45% |
| July, 2029 | $1.3661 | $1.3433 | $0.6161 | -83.34% |
| August, 2029 | $0.8675 | $0.7703 | $0.9646 | -89.42% |
| September, 2029 | $7.6977 | $8.7485 | $8.30 | -6.13% |
| October, 2029 | $7.5439 | $7.9439 | $7.3086 | -8.00% |
| November, 2029 | $3.8709 | $4.8609 | $5.7332 | -52.79% |
| December, 2029 | $6.7879 | $3.6484 | $5.4779 | -17.22% |
Aura Biosciences Inc Stock (AURA) Price Forecast for 2030
Aura Biosciences Inc Stock (AURA) is expected to reach an average price of $8.1344 in 2030, with a high forecast of $9.466 and a low forecast of $6.8027. This signifies an -0.80% decrease from the last price of $8.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.1141 | $8.0371 | $6.3048 | -13.24% |
| February, 2030 | $8.6711 | $7.2326 | $6.4026 | +5.74% |
| March, 2030 | $9.118 | $9.448 | $9.1788 | +11.20% |
| April, 2030 | $8.665 | $9.4323 | $8.315 | +5.67% |
| May, 2030 | $9.0612 | $6.8027 | $8.9512 | +10.50% |
| June, 2030 | $7.1582 | $7.9382 | $8.3304 | -12.71% |
| July, 2030 | $8.5144 | $7.3974 | $7.8744 | +3.83% |
| August, 2030 | $6.9914 | $8.8864 | $8.7686 | -14.74% |
| September, 2030 | $8.5183 | $7.6498 | $7.4883 | +3.88% |
| October, 2030 | $8.8045 | $9.2576 | $9.466 | +7.37% |
| November, 2030 | $9.6715 | $9.8823 | $9.3115 | +17.95% |
| December, 2030 | $9.4085 | $9.3492 | $8.9185 | +14.74% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):